Objective: To assess the role of pharmacist to improve the patient economy in regard to treatment of diabetes mellitus (DM).
Methodology: Total 150 Questionnaire were distributed among diabetic patients and 83 were male (55.4%) and 67(44.6%) female. Out of 150, 27(18%) patients had type 1 and 123(82%) had type 2 DM.
Results: Glimperide (1mg) revealed maximum price variation of 655.38% while glipizide (10mg) showed difference of 38.88%. Metformin (500mg) and pioglitazone (15mg) showed profound price variation of 308.33% & 542%, respectively.
Conclusion: The study has shown that the pharmacist can be very helpful in decreasing the substantial cost incurred by patients. The beneficiary is not only the patient, his family but the whole society and the whole country is beneficiary of pharmacist intervention
Intervention, pharmacist, diabetes mellitus, cost
Cost-Effectiveness of Sonography-Guided Surgery.
Kinanga R, Moungondo F
Hand clinics. 2022; 38(1): 65-73
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299
Evaluating the Efficacy of Combined P188 Treatment and Surgical Intervention in Preventing Post-Traumatic Osteoarthritis Following a Traumatic Knee Injury.
Narez GE, Brown G, Herrick A, Ek RJ, Dejardin L, Wei F, Haut RC, Haut Donahue TL
Journal of biomechanical engineering. 2022; 144(4):
Socioeconomic Status and Individual Personal Responsibility Beliefs Towards Food Access.
Coleman RA, Fulford MD
Food ethics. 2022; 7(1): 1
Economic Evaluation of Total Laboratory Automation in the Clinical Laboratory of a Tertiary Care Hospital.
Kim K, Lee SG, Kim TH, Lee SG
Annals of laboratory medicine. 2022; 42(1): 89-95